Cite

    Ma, A., Gurnasinghani, S., Kirk, E. P., McClenaghan, C., Singh, G. K., Grange, D. K., Pandit, C., Zhu, Y., Roscioli, T., Elakis, G., Buckley, M., Mehta, B., Roberts, P., Mervis, J., Biggin, A., & Nichols, C. G. (2019). glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain‐of‐function variant: Initial experience. American journal of medical genetics, 179(8), 1585–1590. http://access.bl.uk/ark:/81055/vdc_100088877050.0x000029